The November edition of Small Molecules of the Month includes two oral SARS-CoV-2 antivirals which may play an important role in life with endemic Covid, a remarkably selective CDK7 kinase inhibitor (>4000x), and a recently approved, once-daily MET inhibitor. If you find this series helpful, keep a close eye on drughunter.com in the coming days to catch what the team’s been working on for you behind the scenes…
November 2021
- paxlovid
- GS-621763
- ASP2453
- SY-5609
- BIIB091
- "compound Ia"
- DS96432529
- "compound 27"
- tepotinib
- PF-06939999
- "compound 5"
- compound 59
- M5717
- compound 1